Frontlight ResearchEarly access
Pulmonary arterial hypertension trials in India
1 trial · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleA Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in India (MK-7962-037)
- Where
- Belagavi, Chennai, Hyderabad
- Age
- 18 years and over
- People
- 30
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07600723